- Home
- TRP vs BDX Comparison
TRP vs BDX Comparison
Compare TRP & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRP
- BDX
- Stock Information
- Founded
- TRP 1951
- BDX 1897
- Country
- TRP Canada
- BDX United States
- Employees
- TRP N/A
- BDX N/A
- Industry
- TRP
- BDX Medical/Dental Instruments
- Sector
- TRP
- BDX Health Care
- Exchange
- TRP Nasdaq
- BDX Nasdaq
- Market Cap
- TRP 55.6B
- BDX 49.0B
- IPO Year
- TRP N/A
- BDX 1962
- Fundamental
- Price
- TRP $51.76
- BDX $186.79
- Analyst Decision
- TRP Hold
- BDX Buy
- Analyst Count
- TRP 3
- BDX 9
- Target Price
- TRP $62.00
- BDX $212.88
- AVG Volume (30 Days)
- TRP 2.1M
- BDX 1.3M
- Earning Date
- TRP 11-06-2025
- BDX 11-06-2025
- Dividend Yield
- TRP 4.64%
- BDX 2.23%
- EPS Growth
- TRP 23.31
- BDX 12.91
- EPS
- TRP 2.99
- BDX 5.47
- Revenue
- TRP $10,486,413,556.00
- BDX $21,386,000,000.00
- Revenue This Year
- TRP $11.99
- BDX $9.44
- Revenue Next Year
- TRP $5.26
- BDX $4.54
- P/E Ratio
- TRP $17.30
- BDX $34.14
- Revenue Growth
- TRP 15.85
- BDX 7.86
- 52 Week Low
- TRP $43.51
- BDX $163.33
- 52 Week High
- TRP $55.37
- BDX $251.99
- Technical
- Relative Strength Index (RSI)
- TRP 40.97
- BDX 46.08
- Support Level
- TRP $52.64
- BDX $185.50
- Resistance Level
- TRP $55.37
- BDX $194.68
- Average True Range (ATR)
- TRP 0.93
- BDX 3.59
- MACD
- TRP -0.38
- BDX -0.22
- Stochastic Oscillator
- TRP 0.28
- BDX 41.18
About TRP TC Energy Corporation
TC Energy operates natural gas transmission assets across North America. Segments are determined by country of operation, but both Canadian and US operations are interconnected. Mexican operations are disconnected from the US and only have one customer, the state utility CFE. They also operate power generation assets, with the largest being the Bruce Power nuclear plant.
About BDX Becton Dickinson and Company
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2024 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.